NewslettersPancreatic Cell News Open Letter Regarding the Use of Mounjaro® and Zepbound™ By Laurisa Dohm - January 12, 2024 0 Lilly Stands Against the Use of its Medicines for Cosmetic Weight Loss: Mounjaro and Zepbound are indicated for the treatment of serious diseases; they are not approved for – and should not be used for – cosmetic weight loss. [Eli Lilly] Press Release